Large-scale analysis of the prevalence and geographic distribution of HIV-1 non-B variants in the United States

Journal of Clinical Microbiology

Volumn 51, Issue 8, 2013, Pages 2662-2669

  Pyne, Michael T ^a   Hackett, John ^b   Holzmayer, Vera ^b   Hillyard, David R ^a,c  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b ABBOTT DIAGNOSTICS   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DISEASE SURVEILLANCE; EPIDEMIOLOGICAL DATA; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE B; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SPECIES DIVERSITY; UNINDEXED SEQUENCE; VIRUS DETECTION; VIRUS LOAD; VIRUS RECOMBINANT; VIRUS STRAIN;

EID: 84880579305     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00880-13     Document Type: Article

References (57)

1. Plantier JC, Leoz M, Dickerson JE, de Oliveira F, Cordonnier F, Lemée V, Damond F, Robertson DL, Simon F. 2009. A new human immunodeficiency virus derived from gorillas. Nat. Med. 15:871-872.
2. Kuiken C, Foley B, Leitner T, Apetrei C, Hahn B, Mizrachi I, Mullins J, Rambaut A, Wolinsky S, Korber B (ed). 2011. HIV Sequence Compendium 2011. Los Alamos National Laboratory, Los Alamos, NM.
3. McCutchan FE. 2006. Global epidemiology of HIV. J. Med. Virol. 78:S7-S12.
4. Hemelaar J, Gouws E, Ghys PD, Osmanov S. WHO-UNAIDS Network for HIV Isolation and Characterisation. 2011. Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 25:679-689.
5. Swanson P, de Mendoza C, Joshi J, Goldan A, Hodinka RL, Soriano V, Devare SG, Hackett J, Jr. 2005. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT. J. Clin. Microbiol. 43:3860-3868.
6. Gueudin M, Plantier JC, Lemée V, Schmitt MP, Chartier L, Bourlet T, Ruffault A, Damond F, Vray M, Simon F. 2007. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J. Acquir. Immune Defic. Syndr. 44:500-505.
7. Ly TD, Ebel A, Faucher V, Fihman V, Laperche S. 2007. Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays? J. Virol. Methods 143:86-94.
8. Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM. 2008. The challenge of HIV-1 subtype diversity. N. Engl. J. Med. 358:1590-1602.
9. Church D, Gregson D, Lloyd T, Klein M, Beckthold B, Laupland K, Gill MJ. 2011. Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q. v1.2, and Versant v3.0 assays for determination of HIV-1 viral loads in a cohort of Canadian patients with diverse HIV subtype infections. J. Clin. Microbiol. 49:118-124.
10. Wainberg MA, Brenner BG. 2012. The impact of HIV genetic polymorphisms and subtype differences on the occurrence of resistance to antiretroviral drugs. Mol. Biol. Int. 2012:256982. doi:10.1155/2012/256982.
11. Saison J, Tardy JC, Scholtes C, Icard V, Trabaud MA, Perpoint T, Chidiac C, Ecohard R, André P, Ferry T. Lyon HIV Cohort Study. 2013. Low-level viremia is associated with non-B subtypes in patients infected with HIV with virological success following HAART introduction. J. Med. Virol. 85:953-958.
12. Pyne MT, Brown KL, Hillyard DR. 2010. Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test and identification of rare polymorphisms potentially affecting assay performance. J. Clin. Microbiol. 48: 2852-2858.
13. + T-cell count and viral load in an untreated patient infected with a subtype F strain. J. Acquir. Immune Defic. Syndr. 52:659-661.
14. Jennings C, Harty B, Granger S, Wager C, Crump JA, Fiscus SA, Bremer JW. 2012. Cross-platform analysis of HIV-1 RNA data generated by a multicenter assay validation study with wide geographic representation. J. Clin. Microbiol. 50:2737-2747.
15. Chudy M, Weber-Schehl M, Pichl L, Jork C, Kress J, Heiden M, Funk MB, Nübling CM. 2012. Blood screening nucleic acid amplification test for human immunodeficiency virus type 1 may require two different amplification targets. Transfusion 52:431-439.
16. Karasi JC, Dziezuk F, Quennery L, Förster S, Reischl U, Colucci G, Schoener D, Sequin-Devaux C, Schmit JC. 2011. High correlation between Roche COBAS Ampliprep/COBAS TaqMan HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes. J. Clin. Virol. 52:181-186.
17. Ly TD, Plantier JC, Lebaillais L, Gonzalo S, Lemée V, Laperche S. 2012. The variable sensitivity of HIV Ag/Ab combination assays in the detection of p24 Ag according to genotype could compromise the diagnosis of early HIV infection. J. Clin. Virol. 55:121-127.
18. Barin F, Courouce A-M, Pillonel J, Buzelay L. 1997. Increasing diversity of HIV-1M serotypes in French blood donors over a 10-year period (1985-1995). AIDS 11:1503-1508.
19. Couturier E, Damond F, Roques P, Fleury H, Barin F, Brunet JB, Brun-Vézinet F, Simon F. 2000. HIV-1 diversity in France, 1996-1998. AIDS 14:289-296.
20. Lot F, Samaille C, Cazein F, Barin F, Pinget R, Pillonel J, Desenclos JC. 2004. Preliminary results from the new HIV surveillance system in France. Euro Surveill. 9:34-37.
21. Semaille C, Barin F, Cazein F, Pillonel J, Lot F, Brand D, Plantier JC, Bernillon P, Le Vu S, Pinget R, Desenclos JC. 2007. Monitoring the dynamics of the HIV epidemic using assays for recent infection and serotyping among new HIV diagnoses: experience after 2 years in France. J. Infect. Dis. 196:377-383.
22. Parry JV, Murphy G, Barlow KL, Lewis K, Rogers PA, Belda FJ, Nicoll A, McGarrigle C, Cliffe S, Mortimer PP, Clewley JP. 2001. National surveillance of HIV-1 subtypes for England and Wales: design, methods, and initial findings. J. Acquir. Immune Defic. Syndr. 26:381-388.
23. Vercauteren J, Wensing AMJ, van de Vijver DAMC, Alvert J, Balotta C, Hamouda O, Kücherer C, Struck D, Schmit JC, Asjö B, Bruckova M, Camacho RJ, Clotet B, Coughlan S, Grossman Z, Horban A, Korn K, Kostrikis L, Nielsen C, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Riva C, Ruiz L, Salminen M, Schuurman R, Sonnerborg A, Stanekova D, Stanojevic M, Vandamme AM, Boucher CA. 2009. Transmission of drug-resistant HIV-1 is stabilizing in Europe. J. Infect. Dis. 200:1503-1508.
24. Bennett D. 2005. HIV-1 genetic diversity surveillance in the United States. J. Infect. Dis. 192:4-9.
25. Brodine SK, Shaffer RA, Starkey MJ, Tasker SA, Gilcrest JL, Louder MK, Barile A, VanCott TC, Vahey MT, McCutchan FE, Birx DL, Richman DD, Mascola JR. 1999. Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion. Ann. Intern. Med. 131:502-506.
26. Wegner SA, Larder B, Hertogs K, Carr J, McCutchan F. 2000. Use of a drug resistance sequence database to determine the prevalence of nonsubtype B HIV-1 infections in US and European clinical cohorts, abstr 177. Antiviral Ther. 5(Suppl 3):136-145.
27. Achkar JM, Burda ST, Konings FAJ, Urbanski MM, Silliams CA, Seifen D, Kahirimbanyi MN, Vogler M, Parta M, Lupatkin HC, Zolla-Pazner S, Nyambi PN. 2004. Infection with HIV type 1 groupMnon-B subtypes in individuals living in New York City. J. Acquir. Immune Defic. Syndr. 36:835-844.
28. Sides TL, Akinsete O, Henry K, Wotton JT, Carr PW, Bartkus J. 2005. HIV-1 subtype diversity in Minnesota. J. Infect. Dis. 192:37-45.
29. Lin H-H, Gaschen BK, Collie M, El-Fishaway M, Chen Z, Korber BT, Beatrice ST, Zhang L. 2006. Genetic characterization of diverse HIV-1 strains in an immigrant population living in New York City. J. Acquir. Immune Defic. Syndr. 41:399-404.
30. Brennan CA, Stramer SL, Holzmayer V, Yamaguchi J, Foster GA, Notari Iv EP, Schochetman G, Devare SG. 2009. Identification of human immunodeficiency virus type 1 non-B subtypes and antiretroviral drugresistant strains in United States blood donors. Transfusion 49:125-133.
31. Delwart E, Slikas E, Stramer SL, Kamel H, Kessler D, Krysztof D, Tobler LH, Carrick DM, Steele W, Todd D, Wright DJ, Kleinman SH, Busch MP, NHLBI-REDS-II Study Group. 2012. Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors. J. Infect. Dis. 205:875-885.
32. Wheeler W, Mahle K, Bodnar U, Pienaizek D, Kline R, Hall I, McKenna M, US Variant, Atypical and Resistant HIV Surveillance (VARHS) Group. 2007. Antiretroviral drug-resistance mutations and subtypes in drug-naïve persons newly diagnosed with HIV-1 infection, US, March 2003 to October 2006. CDC, Atlanta, GA. http://www.retroconference.org/2007/PDFs/648.pdf.
33. Brennan CA. 2007. Review of status of HIV strain diversity in the United States. J. Med. Virol. 79:S27-S31.
34. Carr JK, Osinusi A, Flynn CP, Gilliam BL, Maheshwari V, Zhao RY. 2010. Two independent epidemics of HIV in Maryland. J. Acquir. Immune Defic. Syndr. 54:297-303.
35. Gonzales MJ, Machekano RN, Shafer RW. 2001. Human immunodeficiency virus type 1 reverse-transcriptase and protease subtypes: classification, amino acid mutation patterns, and prevalence in a northern California clinic-based population. J. Infect. Dis. 184:998-1006.
36. Cartwright CP. 2006. The changing epidemiology of HIV/AIDS at a Minnesota hospital: impact of demographic change and viral diversity. J. Med. Virol. 78:S19-S21.
37. Wheeler WH, Ziebell RA, Zabina H, Pieniazek D, Prejean J, Bodnar UR, Mahle KC, Heneine W, Johnson JA, Hall HI, Variant Atypical and Resistant HIV Surveillance Group. 2010. Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006. AIDS 24:1203-1212.
38. United States Census Bureau. 2011. The newly arrived foreign-born population of the United States: 2010. United States Census Bureau, U.S. Department of Commerce, Suitland, MD. http://www.census.gov/prod/2011pubs/ acsbr10-16.pdf.
39. de Oliveira CF, Diaz RS, Machado DM, Sullivan MT, Finlayson T, Gwinn M, Lackritz EM, Williams AE, Kessler D, Operskalski EA, Mosley JW, Busch MP. 2000. Surveillance of HIV-1 genetic subtypes and diversity in the US blood supply. Transfusion 40:1399-1406.
40. Ebbert MTW, Mallory MA, Wilson AR, Dooley SK, Hillyard DR. 2013. Application of a new informatics tool for contamination screening in the HIV sequencing laboratory. J. Clin. Virol. 57:249-253.
41. Gao F, Yue L, Hill SC, Robertson DL, Graves AH, Saag MS, Shaw GM, Sharp PM, Hahn BH. 1994. HIV-1 sequence subtype D in the United States. AIDS Res. Hum. Retroviruses 10:625-627.
42. Brodine SK, Mascola JR, Weiss PJ, Ito SI, Porter KR, Artenstein AW, Garland FC, McCutchan FE, Burke DS. 1995. Detection of diverse HIV-1 genetic subtypes in the U. S. A. Lancet 346:1198-1199.
43. Walter EA, Gilliam B, Delmar JA, Spooner K, Morris JT, Aronson N, Wegner SA, Michael NL, Jagodzinski LL. 2000. Clinical implications of identifying non-B subtypes of human immunodeficiency virus type 1 infection. Clin. Infect. Dis. 31:798-802.
44. Artenstein AW, Ohl CA, VanCott TC, Hegerich PA, Mascola JR. 1996. Transmission of HIV-1 subtype E in the United States. JAMA 276:99-100.
45. Womack C, Roth W, Newman C, Rissing JP, Lovell R, Haburchak D, Essex M, Bond VC. 2001. Identification of non-B human immunodeficiency virus type 1 subtypes in rural Georgia. J. Infect. Dis. 183:138-142.
46. Hanna GJ, Balaguera HU, Freedberg KA, Werner BG, Seger Craven KA, Craven DE, D'Aguila RT. 2003. Drug-selected resistance mutations and non-B subtypes in antiviral-naive adults with established human immunodeficiency virus infection. J. Infect. Dis. 188:986-991.
47. Parker MM, Gordon D, Reilly A, Horowitz HW, Waters M, Bennett R, Hallack R, Smith J, Lamson D, Aydemir A, Dvali N, Agins BD, Drusano GL, Taylor J, Resistance Study Group. 2007. Prevalence of drug resistant and nonsubtype B strains in antiretroviral-naïve, HIV-infected individuals in New York State. AIDS Patient Care STDS 21:644-652.
48. Karchava M, Pulver W, Smith L, Philpott S, Sullivan TJ, Wethers J, Parker MM. 2006. Prevalence of drug-resistance mutations and nonsubtype B strains among HIV-infected infants from New York State. J. Acquir. Immune Defic. Syndr. 42:614-619.
49. Pieniazek D, Ziebell R, Ocfemia CB, Saduvala N, Kline R, Prejean J, Kim D, Hall HI, US Variant, Atypical and Resistant HIV Surveillance (VARHS) Group. 2012. Phylogenetic surveillance of HIV-1 non-B subtypes among US-born and foreign-born individuals living in the United States revealed similar viral genetic diversity but different race and male transmission patterns. CDC, Atlanta, GA. http://www.retroconference.org/2012b/PDFs/516.pdf.
50. Panel on Antiretroviral Guidelines for Adults and Adolescents. 2013. Guidelines for the use of antiretroviral agents in HIV-1 infected adults and adolescents. National Institutes of Health, Rockville, MD. http://aidsinfo.nih. gov/ContentFiles/AdultandAdolescentGL.pdf.
51. Yebra G, de Mulder M, Martín L, Pérez-Cachafeiro S, Rodríguez C, Labarga P, García F, Tural C, Jaén A, Navarro G, Holguín A, Cohort of Spanish AIDS Research Network (CoRIS). 2011. Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of naïve HIV-infected patients (CoRIS). Antiviral Res. 89:19-25.
52. Aggarwal I, Smith M, Tatt ID, Murad S, Osner N, Geretti AM, Easterbrook PJ. 2006. Evidence of onward transmission of HIV-1 non-B subtype strains in the United Kingdom. J. Acquir. Immune Defic. Syndr. 41:201-209.
53. Luft LM, Beckthold B, Gill MJ. 2011. Increasing HIV subtype diversity in Canadian-born patients living in Southern Alberta, Canada. J. Acquir. Immune Defic. Syndr. 57:e27-e29.
54. Gaudy C, Moreau A, Brunet S, Descamps JM, Deleplangue P, Brand D, Barin F. 2004. Subtype B human immunodeficiency virus (HIV) type 1 mutant that escapes detection in a fourth-generation immunoassay for HIV infection. J. Clin. Microbiol. 42:2847-2849.
55. Henquell C, Jacomet C, Antoniotti O, Chaib A, Regagnon C, Brunet S, Peigue-Lafeuille H, Barin F. 2008. Difficulties in diagnosing group O human immunodeficiency virus type 1 acute primary infection. J. Clin. Microbiol. 46:2453-2456.
56. van Rensburg EJ, Tait K, Watt A, Schall R. 2011. Comparative evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 version 2 test using the TaqMan 48 analyzer and the Abbott RealTime HIV-1 assay. J. Clin. Microbiol. 49:377-379.
57. Troppan KT, Stelzl E, Violan D, Winkler M, Kessler HH. 2009. Evaluation of the new Versant HIV-1 RNA 1.0 assay (kPCR) for quantitative detection of human immunodeficiency virus type 1 RNA. J. Clin. Virol. 46:69-74.